MustGrow Begins Testing Formulation Against Banana Panama Disease

MustGrow Biologics (CSE: MGRO) has begun testing its proprietary mustard-based formulation against Panama Disease, a pathogen that has been ravaging the global banana industry. The laboratory testing, to take place in Colombia, will look to provide a treatment for the pathogen.

The testing of TerraMG bio-pesticide for use against Panama Disease is a result of the formulation being proven to control soil-borne pathogens similar to the disease. Independent studies have shown that the product has had 100% control of Fusarium oxysporum, a relative of the disease commonly referred to as Panama disease.

Panama disease is a soil-borne pathogen that can remain in soil for decades, and for which there is currently no effective treatment available. The disease is so devastating that it can result in 100% yield loss, threatening the livelihoods of farmers. The disease threatens the entire $25 billion global banana industry, with the country of Colombia declaring a national state of emergency last year in connection to the disease. It has a particular affinity for the cavendish banana, the most commonly consumed banana globally for which approximately half of all global banana production consists of.

Laboratory results from the study are expected in the fourth quarter of 2020. MustGrow is presently looking to build on its existing field data to achieve registrational labels in Colombia and other South American agricultural industries. The company has been working towards registration in both the US and Canada for TerraMG, as it looks to receive approval for the formulation as a treatment of soil-borne pests and disease for high value crops.

MustGrow Biologics last traded at $0.36 on the CSE.


FULL DISCLOSURE: MustGrow Biologics Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover MustGrow Biologics Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

When 4% of Global Copper Disappears Overnight | David Gower – Emerita Resources

Mining M&A: Gold X2 Acquires Kesselrun Resources

They Said Oil Was Dead. They Were Wrong. | Michael Judson – Record Resources

Recommended

Steadright Secures Two Additional Exploration Licenses For Flagship Project

First Majestic Posts Record Quarterly Silver Production In Q3

Related News

MustGrow Biologics Demonstrates 100% Control Of Panama Disease In Lab Tests

MustGrow Biologics (CSE: MGRO) has received the results from initial laboratory testing that was conducted...

Tuesday, December 1, 2020, 08:31:08 AM

MustGrow Begins Testing On Clubroot Disease For Canola Crops

MustGrow Biologics Corp (CSE: MGRO) is looking to potentially expand the effective diseases in which...

Tuesday, February 25, 2020, 08:35:13 AM

Curing The Banana Panama Disease – The Daily Dive feat Colin Bletsky of MustGrow Biologics

Kickstarting our short holiday week for the Daily Dive is that of Colin Bletsky, COO...

Monday, December 21, 2020, 01:00:00 PM

MustGrow Secures Patent For Mustard-Based Sprout Suppressant

MustGrow Biologics (CSE: MGRO) is pushing forward with its focus on natural biopesticides, this morning...

Monday, November 23, 2020, 07:27:00 AM

MustGrow Study Reveals 96.1% Disease Control Of Clubroot Via Greenhouse Tests With TerraMG

MustGrow Biologics (CSE: MGRO) this morning released results from its successful greenhouse soil test results...

Wednesday, August 26, 2020, 09:28:03 AM